Leniolisib: A Novel Drug Being Investigated for Treatment of APDS, a Rare Primary Immunodeficiency

Event Type:
Webinars
Date:
Thursday, September 15, 2022, 2-3pm ET
Member:
Free
Non-Member:
Free

AMCP Ad Block

AMCP Ad Block